CancerFax
CLINICAL TRIALS

HOW TO APPLY FOR
A CLINICAL TRIAL

The clinical trial application process follows predictable steps on predictable timelines. Knowing them in advance makes the weeks between finding a trial and starting one feel like a process rather than a wait.

Reviewed by: CancerFax Medical Team, Oncology & Haematology SpecialistsLast reviewed: April 16, 20268 min read

The Clinical Trial Application Process

  1. 1

    Step 1: Initial Site Contact

    Contact the coordinator for the trial at the site you are considering. Provide: your cancer diagnosis, current disease status, prior treatments, key molecular results, and why you are enquiring about this specific trial. Ask directly whether patients with your profile have been enrolling.

  2. 2

    Step 2: Informal Pre-Screening

    The coordinator compares your summary against major eligibility criteria. Not a formal eligibility determination -- a screen for obvious incompatibilities before the more intensive formal evaluation begins.

  3. 3

    Step 3: Documentation Assembly

    Gather: pathology reports, NGS/molecular testing results, treatment summaries with dates and agents, recent imaging reports (within 60-90 days), recent laboratory results (often within 28 days). Organise chronologically. Gaps in documentation cause the most common delays.

  4. 4

    Step 4: Formal Eligibility Screening

    Trial team reviews complete documentation systematically. Additional testing may be required -- current labs, updated imaging, sometimes a biopsy. This step takes time and cannot be rushed without compromising accuracy.

  5. 5

    Step 5: Informed Consent

    If confirmed eligible: detailed review of what the trial involves, risks as currently understood, your rights including right to withdraw, and what happens if the trial ends early. Read it thoroughly. Ask questions. This is not paperwork.

  6. 6

    Step 6: Baseline Assessments

    Before treatment begins, the trial team establishes baseline measurements that future assessments will be compared against. Imaging, labs, quality of life questionnaires, sometimes biomarker assessments. These become the reference points for evaluating treatment response.

Frequently Asked Questions

    How CancerFax Helps

    CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

    description
    Medical Record Review

    We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

    verified_user
    Eligibility Coordination

    We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

    hub
    Hospital Communication

    We support appointment coordination, document submission, translation, and direct communication with international departments.

    flight
    Travel & Admission Support

    For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

    explore
    Treatment & Trial Navigation

    If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

    support_agent
    End-to-end Coordination

    From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

    CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

    Need Help Navigating the Clinical Trial Application Process?

    CancerFax assists patients through every step of the clinical trial application process -- from initial site contact to documentation assembly and eligibility screening coordination.

    This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.